ClinicalTrials.gg
RecruitingNCT06898554Updated Mar 27, 2025

Spinal and Supraspinal Control in Chronic Ankle Instability

An interventional study of The structured balance training protocol in Ankle Injuries and Ankle Sprains, sponsored by Ayca Yagcioglu. Recruiting at 2 sites in Turkey. Open to participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2025-03-27.

Sponsored by Ayca Yagcioglu · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Registered 4 months after the study started (first participant enrolled Nov 2024, registered Mar 2025).
  • Started Nov 2024; still recruiting 2 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 38 studies in Ankle Injuries with a site in Turkey — 8 open to participants now, 11 under way, none of them phase 3. Ankle Injuries · Turkey.

Planned enrollment
22nd of 26
30 · median 45
Started
2024
with 6 others
No phase
23 of 38
7 open now
Primary completion
2025-06
later than 4 of 10 live
Registered
29th of 38
by date

Among the 38 studies in Ankle Injuries with a site in Turkey, this one is the 22nd largest by planned enrollment of the 26 interventional ones that give a count, is one of 7 that started in 2024, is one of 23 with no phase, reaches primary completion later than 4 of the 10 other live ones, and was the 29th registered.

Ankle Injuries

354 studies on the registry are indexed under Ankle Injuries; 77 are open to participants now.

Browse Ankle Injuries studies →

Open to participants now

8 of the 38 studies in Ankle Injuries with a site in Turkey are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 47 Ankle Injuries studies recruiting now, 11 (23%) set no upper age limit and 33 (70%) stop at 75 or younger; 10 take children under 18; 8 take healthy volunteers.

This study: 18 Years to 25 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 38 studies in Ankle Injuries with a site in Turkey, or all of them as a file.
02

Study summary

Ankle sprains are common sports injuries that often lead to chronic ankle instability (CAI). Patients with CAI experience deficits in neuromuscular control (NMC), including proprioception and strength. It is believed that damage to the ankle's ligament mechanoreceptors and the peroneal nerve after the initial ankle sprain can cause alterations in NMC, resulting in postural control and dynamic joint stability dysfunction. Inflammation related to recurrent ankle sprains may also contribute to neuromuscular impairments. Evidence suggests that bilateral postural control deficits occur after an ankle sprain, suggesting alterations in the central nervous system (CNS). Rehabilitation for CAI has been shown to lead to bilateral improvements in NMC, potentially due to neural alterations at both the spinal and supraspinal levels. Cross-education, which refers to the muscular crossed effect of unilateral training, has also been proposed as a mechanism for improving contralateral strength in neurologically healthy individuals. While the exact mechanisms underlying cross-education are not yet fully understood, evidence suggests that it involves neural adaptations at both spinal and supraspinal levels. This study aims to investigate the cross-education effect of a 6-week, unilateral balance training on corticomotor excitability, motor neuron pool excitability, and static and dynamic balance in athletes with chronic ankle instability.

03

Conditions studied

  • Ankle Injuries
  • Ankle Sprains

Keywords

  • ankle, joint instability, cross-education, rehabilitation
04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Volunteering to participate in the study,
  • Being an athlete between the ages of 18-25,
  • Being a player in a field team sport such as basketball, volleyball, and handball,
  • Having a history of at least 2 significant grade II LAS diagnosed by a physician,
  • Related inflammatory symptoms, "giving away" sensation, obtaining a score ≤25 from the Cumberland Ankle Instability Tool (CAIT),
  • A score \<90% for the activities of daily living subscale and \<80% for the sport subscale from the Foot and Ankle Ability Measure,
  • Recurrent episodes of LAS of the injured ankle which occurred within at least 12 months.

Exclusion criteria

Exclusion Criteria:

  • Acute injury of lower extremity musculoskeletal structures in the last three months,
  • Orthopedic surgery in any of the lower extremities,
  • Bilateral ankle instability,
  • Vestibular or balance disorder
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Stable Group

    The intervention will be applied to only the stable ankle of the athletes with unilateral chronic ankle instability.

    Other: The structured balance training protocol

  • Experimental
    Unstable Group

    The intervention will be applied to only the unstable ankle of the athletes with unilateral chronic ankle instability.

    Other: The structured balance training protocol

  • No intervention
    Control Group

    No intervention will be applied.

Interventions

  • OtherThe structured balance training protocol

    The structured balance training protocol consists of 7 exercises including balance and hop stabilization exercises for athletes with chronic ankle instability.

06

What researchers measure

Primary outcomes

  1. Proprioceptive-Stabilometric Assessment

    The Prokin PK 252 will be used for proprioceptive-stabilometric assessment of the lower extremities, incorporating static and dynamic evaluations. The sensorimotor assessment will include the monopodal controlled-load proprioceptive control test and its variant with total load. Participants will perform movements with one foot on the platform, with angular displacements converted into electrical impulses for data acquisition. Static balance will be assessed on a stable platform for 30 seconds per ankle under eyes-open and eyes-closed conditions. Dynamic balance will be measured on an unstable platform under the same conditions. Proprioception will be evaluated on an unstable platform for 90 seconds, guiding the platform through horizontal, diagonal, and circular patterns as per the test program.

    Time frame: at the baseline and end of the intervention, 8 weeks

  2. Transcranial Magnetic Stimulation

    Transcranial Magnetic Stimulation (TMS), a non-invasive neurophysiological technique, will be used to assess motor cortical function. Corticomotor excitability will be evaluated using dual-cone coil TMS to examine adaptations following cross-training after unilateral training. TMS will induce corticospinal volleys of direct (D) and indirect (I) waves. The resting motor threshold (rMT), a biomarker of upper motor neuron function, will be recorded. EMG recordings will assess corticomotor excitability, with Ag/AgCl electrodes placed on the tibialis anterior, peroneus longus, and gastrocnemius medialis muscles, following SENIAM guidelines. Participants will be seated in a TMS chair, and the hotspot in the left primary motor cortex will be identified. The MEP amplitude will be assessed at 120% rMT with 10 repetitions, and latency will be recorded. A 15-minute rest will be observed between muscle tests.

    Time frame: at the baseline and end of the intervention, 8 weeks

  3. Hoffman Reflex

    The H-reflex will be measured to assess motor neuron pool excitability within the spinal loop, aiming to explain the mechanism underlying bilateral adaptations. As a valuable tool for evaluating neurological function in athletes, the H-reflex will provide insights into neurophysiological changes. EMG signals will be pre-amplified and bandpass filtered between 30-300 Hz and recorded from the peroneus longus, tibialis anterior, and gastrocnemius medialis muscles. The tibial nerve will be stimulated using single 1 ms square-wave pulses applied over the popliteal fossa. The test sequence will be randomized between stable and unstable ankles, ensuring balanced measurements. H-reflex excitability will be assessed for both ankles before and after the protocol to determine neuromuscular adaptations.

    Time frame: at the baseline and end of the intervention, 8 weeks

Secondary outcomes

  1. Cumberland Ankle Instability Tool

    Cumberland Ankle Instability Tool (CAIT) containing a 9-item 30-point scale is a valid and reliable questionnaire for distinguishing and measuring the severity of functional instability (FI). Clinically, CAIT is an effective tool for evaluating the severity of FI, monitoring progress, and measuring treatment outcomes. In researches, the CAIT provides the identification, objective definition, and comparison of more homogenous subject groups. Participants scoring 25 or higher are less likely to have FI, while participants scoring 25 or lower are more likely to have FI.

    Time frame: at the baseline and end of the intervention, 8 weeks

  2. Foot and Ankle Ability Measure (FAAM)

    Foot and Ankle Ability Measure (FAAM) is a self-reported tool improved to assess the physical function of individuals with foot and ankle-related musculoskeletal disorders. The valid and reliable Turkish version of FAAM (FAAM-T) was used (intraclass correlation coefficient \[ICC\] = 0.97 for FAAM-ADL and 0.94 for the FAAM-S subscales), which is a 29-item questionnaire, including 21-item Activities of Daily Living (ADL) and 8-item Sports subscales. Each answer is scored on a 5-point Likert scale ranging from 0 to 4. The maximum score is 84 points for the ADL subscale and 32 points for the Sports subscale. The total score is calculated as a percentage score ranging from 0% to 100%.

    Time frame: at the baseline and end of the intervention, 8 weeks

07

Study locations

2 of 2 sites recruiting
  • Yeditepe University Koşuyolu Hospital
    Istanbul, 34718, Turkey
    Recruiting
    • Ayca Yagcioglu, MSc · Contactayca.yagcioglu@yeditepe.edu.tr · +905432800692
    • Berrin Aktekin, MD, Professor · Principal investigator
    • Gülçin Çelik, MSc · Sub investigator
    • Rengin Bilgen, MD · Sub investigator
    • Ayca Yagcioglu, MSc · Sub investigator
  • Yeditepe University
    Istanbul, 34755, Turkey
    Recruiting
    • Ayca Yagcioglu, MSc · Contactayca.yagcioglu@yeditepe.edu.tr · +905432800692
    • Feyza Şule Hantal, PHd · Principal investigator
    • Ayca Yagcioglu, MSc · Sub investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Jun 2025, 7 months after the start.

Of 141 non-industry interventional studies with no phase under Ankle Injuries, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 31. This study's planned 7 months is below that.

Counting every sponsor, half of 144 studies reached it within 9 months; a quarter within 4 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 21, 2025
First posted
Mar 27, 2025
StartActual
Nov 15, 2024
Primary completionEst.
Jun 30, 2025
CompletionEst.
Jul 31, 2025
Last update
Mar 27, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06898554
Lead sponsor
Ayca Yagcioglu
Collaborators
Yeditepe University, Yeditepe University Hospital
Responsible party
Ayca Yagcioglu (MSc, Yeditepe University) — Sponsor-investigator
First posted
Mar 27, 2025
Start date
Nov 15, 2024
Primary completion
Jun 30, 2025 (estimated)
Completion
Jul 31, 2025 (estimated)
Last update
Mar 27, 2025

Study contacts

Ayca Yagcioglu, MSc
Contact
ayca.yagcioglu@yeditepe.edu.tr
+905432800692
Berrin Aktekin, MD, Professor
principal investigator · Yeditepe University Hospital
Feyza Şule Hantal, PHd
principal investigator · Yeditepe University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion